Were they further along? I though some were only in Phase 2, like us. There is a trend now to interrupt a phase 2 trial showing initial positive results and grant approval, especially with something like TNBC. If that's the case it won't take 5 years. The mean survival rate for metastatic TNBC is only about 9 months right now, so if "our" patients start surviving longer, it may be considered enough for early approval.

I'd have to look the companies up, and don't have time right now.